Animal models of venous thrombosis

Cardiovascular Diagnosis and Therapy

Volumn 7, Issue , 2017, Pages S197-S206

  Albadawi, Hassan ^a   Witting, Avery A ^a   Pershad, Yash ^a   Wallace, Alex ^a   Fleck, Andrew R ^a   Hoang, Peter ^a   Khademhosseini, Ali ^b,c   Oklu, Rahmi ^a,b  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Blood coagulation; Experimental animal models; Thrombolytic therapy; Thrombosis; Veins; Venous thrombosis (VT)

Indexed keywords

THROMBIN;

BIOLOGICAL MODEL; BLOOD CLOTTING; CAVA VEIN OBSTRUCTION; DEEP VEIN THROMBOSIS; DISEASE MODEL; ELECTROLYTIC THROMBOSIS MODEL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; FERRIC CHLORIDE-INDUCED THROMBOSIS; FIBRINOLYTIC THERAPY; IN VIVO STUDY; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN OBSTRUCTION; MECHANICAL INJURY MODEL; MECHANICAL THROMBECTOMY; NONHUMAN; PATHOGENESIS; PHOTOCHEMICAL VEIN INJURY; PHOTOCHEMICALLY INDUCED THROMBOSIS; PIG; PORCINE MODEL; REVIEW; STENT GRAFT MODEL; THROMBOSIS; THROMBOTIC CAVAL OCCLUSION; VEIN INJURY; VEIN THROMBOSIS; VENOUS STASIS;

EID: 85038619919     PISSN: 22233652     EISSN: 22233660     Source Type: Journal    
DOI: 10.21037/cdt.2017.08.10     Document Type: Review

References (71)

1. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008;28:370-2.
2. Morris TA. Natural history of venous thromboembolism. Crit Care Clin 2011;27:869-84.
3. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: An administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 2007;13:475-86.
4. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:I4-8.
5. Stanford SN, Sabra A, D'Silva L, et al. The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: A prospective observational study. BMC Neurol 2015;15:35.
6. Henke PK, Comerota AJ. An update on etiology, prevention, and therapy of postthrombotic syndrome. J Vasc Surg 2011;53:500-9.
7. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008;149:698-707.
8. Hillis C, Crowther MA. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants. Thromb Haemost 2015;113:1193-202.
9. Oklu R, Wicky S. Catheter-directed thrombolysis of deep venous thrombosis. Semin Thromb Hemost 2013;39:446-51.
10. Diamond SL. Systems Analysis of Thrombus Formation. Circ Res 2016;118:1348-62.
11. Henke PK, Wakefield T. Thrombus resolution and vein wall injury: Dependence on chemokines and leukocytes. Thromb Res 2009;123 Suppl 4:S72-8.
12. Byrnes JR, Wolberg AS. New findings on venous thrombogenesis. Hamostaseologie 2017;37:25-35.
13. Keller K, Prochaska JH, Coldewey M, et al. History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism. Thromb Res 2015;136:899-906.
14. Diaz JA, Obi AT, Myers DD Jr, et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol 2012;32:556-62.
15. Bernat A, Vallée E, Maffrand JP, et al. Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis. Thromb Res 1985;37:279-85.
16. Doutremepuich C, Gestreau JL, Maury MO, et al. Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction. Haemostasis 1983;13:109-12.
17. Reyers I, Mussoni L, Donati MB, et al. Failure of aspirin at different doses to modify experimental thrombosis in rats. Thromb Res 1980;18:669-74.
18. Thomas DP, Merton RE, Hockley DJ. The effect of stasis on the venous endothelium: An ultrastructural study. Br J Haematol 1983;55:113-22.
19. Hladovec J. A sensitive model of venous thrombosis in rats. Thromb Res 1986;43:539-44.
20. Pescador R, Porta R, Conz A, et al. A quantitative venous thrombosis model with stasis based on vascular lesion. Thromb Res 1989;53:197-201.
21. Solis MM, Cook C, Cook J, et al. Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model. J Vasc Surg 1991;14:599-604.
22. Spokas EG, Wun TC. Venous thrombosis produced in the vena cava of rabbits by vascular damage and stasis. J Pharmacol Toxicol Methods 1992;27:225-32.
23. Thomas DP, Merton RE, Wood RD, et al. The relationship between vessel wall injury and venous thrombosis: An experimental study. Br J Haematol 1985;59:449-57.
24. Vogel GM, Meuleman DG, Bourgondi'n FG, et al. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans. Thromb Res 1989;54:399-410.
25. Wessler S. Thrombosis in the presence of vascular stasis. Am J Med 1962;33:648-66.
26. Wessler S, Gitel SN, Bank H, et al. An assay of the antithrombotic action of warfarin: Its correlation with the inhibition of stasis thrombosis in rabbits. Thromb Haemost 1979;40:486-98.
27. Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992;80:2281-6.
28. Myers DD Jr, Henke PK, Wrobleski SK, et al. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model. J Vasc Surg 2002;36:928-38.
29. Dewyer NA, Sood V, Lynch EM, et al. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 2007;142:357-63.
30. Henke PK, Varma MR, Deatrick KB, et al. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost 2006;95:272-81.
31. Myers DD, Hawley AE, Farris DM, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003;38:1075-89.
32. Myers D Jr, Farris D, Hawley A, et al. Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002;108:212-21.
33. Wojcik BM, Wrobleski SK, Hawley AE, et al. Interleukin-6: A potential target for post-thrombotic syndrome. Ann Vasc Surg 2011;25:229-39.
34. Diaz JA, Ballard-Lipka NE, Farris DM, et al. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis. J Vasc Surg 2012;55:815-22.
35. Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215-21.
36. Pottier P, Planchon B, Truchaud F, et al. Development of an experimental model of pre-thrombosis in rats based on Wessler's principle using a calibrated venous stasis. Blood Coagul Fibrinolysis 2003;14:3-9.
37. Zhou J, May L, Liao P, et al. Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats. Arterioscler Thromb Vasc Biol 2009;29:863-9.
38. Peternel L, Drevensek G, Cerne M, et al. Evaluation of two experimental venous thrombosis models in the rat. Thromb Res 2005;115:527-34.
39. Brill A, Fuchs TA, Savchenko AS, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012;10:136-44.
40. von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012;209:819-35.
41. Brill A, Fuchs TA, Chauhan AK, et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011;117:1400-7.
42. Brandt M, Schönfelder T, Schwenk M, et al. Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches. Clin Hemorheol Microcirc 2014;56:145-52.
43. McGuinness CL, Humphries J, Waltham M, et al. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost 2001;85:1018-24.
44. Myers DD Jr, Henke PK, Bedard PW, et al. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis. J Vasc Surg 2006;44:625-32.
45. Jaffer FA, Tung CH, Gerszten RE, et al. In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe. Arterioscler Thromb Vasc Biol 2002;22:1929-35.
46. Jaffer FA, Tung CH, Wykrzykowska JJ, et al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 2004;110:170-6.
47. Gustafsson D, Nyström J, Carlsson S, et al. The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: Intestinal absorption properties, biochemical and pharmacodynamic effects. Thromb Res 2001;101:171-81.
48. Eitzman DT, Westrick RJ, Nabel EG, et al. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 2000;95:577-80.
49. Pierangeli SS, Barker JH, Stikovac D, et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994;71:670-4.
50. Pierangeli SS, Liu XW, Barker JH, et al. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995;74:1361-7.
51. Cooley BC, Schmeling G. Murine model of large-vein electrolytic injury induction of thrombosis with slow resolution. Thromb Res 2016;140:149-52.
52. Cooley BC, Szema L, Chen CY, et al. A murine model of deep vein thrombosis: Characterization and validation in transgenic mice. Thromb Haemost 2005;94:498-503.
53. Diaz JA, Alvarado CM, Wrobleski SK, et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse. Thromb Haemost 2013;109:1158-69.
54. Diaz JA, Hawley AE, Alvarado CM, et al. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model. Thromb Haemost 2010;104:366-75.
55. Diaz JA, Wrobleski SK, Hawley AE, et al. Electrolytic inferior vena cava model (EIM) of venous thrombosis. J Vis Exp 2011;(53):e2737.
56. Geier B, Barbera L, Muth-Werthmann D, et al. Ultrasound elastography for the age determination of venous thrombi. Evaluation in an animal model of venous thrombosis. Thromb Haemost 2005;93:368-74.
57. Katoh M, Haage P, Spuentrup E, et al. A porcine deep vein thrombosis model for magnetic resonance-guided monitoring of different thrombectomy procedures. Invest Radiol 2007;42:727-31.
58. Katoh M, Haage P, Wiethoff AJ, et al. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: A feasibility study. Invest Radiol 2009;44:146-50.
59. Maxwell AD, Owens G, Gurm HS, et al. Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model. J Vasc Interv Radiol 2011;22:369-77.
60. Geier B, Muth-Werthmann D, Barbera L, et al. Laparoscopic ligation of the infrarenal vena cava in combination with transfemoral thrombin infusion: A new animal model of chronic deep venous thrombosis. Eur J Vasc Endovasc Surg 2005;29:542-8.
61. Lin PH, Chen C, Surowiec SM, et al. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: An endovascular model. J Vasc Surg 2001;33:621-7.
62. Roy S, Laerum F, Brosstad F, et al. Animal model of acute deep vein thrombosis. Cardiovasc Intervent Radiol 1998;21:329-33.
63. Hamer JD, Malone PC. Experimental deep venous thrombogenesis by a non-invasive method. Ann R Coll Surg Engl 1984;66:416-9.
64. Monreal M, Silveira P, Monreal L, et al. Comparative study on the antithrombotic efficacy of four low-molecular-weight heparins in three different models of experimental venous thrombosis. Haemostasis 1991;21:91-7.
65. Wang J, Tan HQ, Li MH, et al. Development of a new model of transvenous thrombosis in the pig superior sagittal sinus using thrombin injection and balloon occlusion. J Neuroradiol 2010;37:109-15.
66. Minko P, Bucker A, Laschke M, et al. Mechanical thrombectomy of iliac vein thrombosis in a pig model using the Rotarex and Aspirex catheters. Cardiovasc Intervent Radiol 2014;37:211-7.
67. Robinson VJ, Pineda GE, Salah AK, et al. Latex D-dimer signal in in situ femoral vein thrombus in swine and effect of minidose exogenous tissue plasminogen activator bolus. Chest 2005;127:622-9.
68. Shi WY, Wu S, Hu LY, et al. Swine Model of Thrombotic Caval Occlusion Created by Autologous Thrombus Injection with Assistance of Intra-caval Net Knitting. Sci Rep 2015;5:18546.
69. Gailani D, Cheng Q, Ivanov IS. Murine models in the evaluation of heparan sulfate-based anticoagulants. Methods Mol Biol 2015;1229:483-96.
70. Westrick RJ, Winn ME, Eitzman DT. Murine models of vascular thrombosis (Eitzman series). Arterioscler Thromb Vasc Biol 2007;27:2079-93.
71. Jagadeeswaran P, Cooley BC, Gross PL, et al. Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs. Circ Res 2016;118:1363-79.